組織相容性復(fù)合體α抗體
規(guī)格：1mg/1ml
英文名： HLA DM
別名： Class II histocompatibility antigen M alpha chain; D6S222E; DMA; HLA class II histocompatibility antigen DM alpha chain; HLA DMA; HLADM; Major histocompatibility complex class II DM alpha; MHC class I
分子量： 26kDa
儲存液：0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glyce
克隆類型：Polyclonal
亞型：IgG
純化方法：affinity purified by Protein A
**原：KLH conjugated synthetic peptide derived from human HLA DM
交叉反應(yīng)：Human, Mouse, Rat, Dog, Pig, Cow, Horse,
細胞定位：細胞漿 細胞膜
組織相容性復(fù)合體α抗體產(chǎn)品介紹：background: Human Leukocyte Antigens are highly polymorphic proteins that are involved in the presentation of antigens to the T-cell receptor. There are two classes of HLA antigens, class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). This antibody can be used for HLA typing. HLA DM plays a critical role in catalyzing the release of class II HLA-associated invariant chain-derived peptides (CLIP) from newly synthesized class II HLA molecules and freeing the peptide binding site for acquisition of組織相容性復(fù)合體α抗體 antigenic peptides. Subunit: Heterodimer of an alpha chain (DMA) and a beta chain (DMB). Subcellular Location: Late endosome membrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Similarity: 組織相容性復(fù)合體α抗體Belongs to the MHC class II family. Contains 1 Ig-like C1-type (immunoglobulin-like) domain. Database links: UniProtKB/Swiss-Prot: P28067.1 Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
組織相容性復(fù)合體α抗體產(chǎn)品應(yīng)用：WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200 （石蠟切片需做抗原修復(fù)） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.
研究領(lǐng)域：細胞生物 **學(xué)
儲存條件： Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
來源： Rabbit
外觀： Lyophilized or Liquid
- 溫馨提示：為規(guī)避購買風(fēng)險，建議您在購買前務(wù)必確認供應(yīng)商資質(zhì)與產(chǎn)品質(zhì)量。
- 免責(zé)申明：以上內(nèi)容為注冊會員自行發(fā)布，若信息的真實性、合法性存在爭議，平臺將會監(jiān)督協(xié)助處理，歡迎舉報